Encompass Health Corp (EHC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $13.94B
Last updated: Nov 17, 2026 at 4:20 PM ET
Encompass Health Corp (EHC) Statistics
Encompass Health (EHC) has a market cap of $13.94B and an enterprise value of $16.47B. Its share count is down 2.19% from a year earlier.
Total Valuation
Enterprise value is 18.09% above the market cap, as debt exceeds cash.
| Market Cap | $13.94B |
|---|---|
| Enterprise Value | $16.47B |
| Latest price (Nov 17, 2026) | $137.84 |
Key Dates
The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Jan 4, 2027.
| Next Earnings Date | Feb 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 28, 2026 |
| Next Ex-Dividend Date | Jan 4, 2027 |
| Next Payment Date | Jan 15, 2027 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 2.1x. Its year-end P/E ranged from 15.5x to 28.6x from 2017 to 2025.
| P/E Ratio | 22.5x |
|---|---|
| Forward P/E | 21.9x |
| P/S Ratio | 2.1x |
| Forward P/S | 2.2x |
| P/FCF Ratio | 29.6x |
| P/OCF Ratio | 10.7x |
| PEG Ratio | 1.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 10.3x EBITDA and 35.2x free cash flow.
| EV / Earnings | 19.1x |
|---|---|
| EV / Sales | 2.6x |
| EV / EBITDA | 10.3x |
| EV / EBIT | 13.8x |
| EV / FCF | 35.2x |
Price Statistics
The stock is up 22.18% over 52 weeks and trades 8.24% above its 50-day average.
| Beta (1Y) | -0.01 |
|---|---|
| 52-Week Change | +22.18% |
| 1-Month Change | +13.26% |
| 3-Month Change | +13.43% |
| 6-Month Change | +32.06% |
| 5-Year Change | +113.81% |
| Total Return (1Y) | +22.87% |
| Total Return (3Y CAGR) | +29.76% |
| Total Return (5Y CAGR) | +23.55% |
| Return vs SPY (1Y) | +11.47% |
| Max Drawdown (1Y) | -19.14% |
| Max Drawdown (3Y) | -26.09% |
| Sharpe Ratio (1Y) | 0.69 |
| Correlation with SPY (1Y) | -0.01 |
| 50-Day Average | $127.35 |
| 200-Day Average | $112.36 |
| 52-Week Range | $92.25 to $143.90 |
| RSI (14 Days) | 57.3 |
| Average Volume (20 Days) | 1.11M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.09x current liabilities.
| Current Ratio | 1.09x |
|---|---|
| Quick Ratio | 1.09x |
| Debt / EBITDA | 1.67x |
| Debt / FCF | 5.68x |
| Interest Coverage | 9.16x |
Returns and Efficiency
| Return on Assets (ROA) | 11.40% |
|---|---|
| Return on Capital Employed (ROCE) | 18.00% |
| ROA (5Y Average) | 8.29% |
| ROIC (5Y Average) | 12.77% |
| Asset Turnover | 0.88x |
| Receivables Turnover | 9.06x |
Taxes
Income tax took 20.53% of pretax income over the last 12 months.
| Income Tax (TTM) | $218.80M |
|---|---|
| Effective Tax Rate | 20.53% |
Scores
EHC has an Altman Z-Score of 3.40, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.40 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $6.34B over the last 12 months is up 9.36% from the 12 months before.
| Revenue | $6.34B |
|---|---|
| Revenue Growth (YoY) | +9.36% |
| Gross Profit | $3.00B |
| Operating Income | $1.16B |
| Pretax Income | $1.07B |
| Net Income | $862.30M |
| EBITDA | $1.55B |
| EBIT | $1.19B |
| Reported EPS (TTM) | $6.13 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $76.20M |
|---|---|
| Total Debt | $2.60B |
| Net Debt | $2.52B |
| Net Debt Per Share | $25.67 |
| Working Capital | $85.60M |
| Shareholder Equity | $0 |
| Tangible Book Value | -$1.63B |
| Total Assets | $7.57B |
| Total Liabilities | $4.01B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $846.50M of capital spending, operating cash flow left $457.20M of free cash flow.
| Operating Cash Flow | $1.30B |
|---|---|
| Capital Expenditures | $846.50M |
| Free Cash Flow | $457.20M |
| FCF Per Share | $4.65 |
| Depreciation and Amortization | $359.80M |
| Dividends Paid | $261.40M |
| Share Repurchases | $280.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 18.32%, against a 5-year average of 16.00%.
| Gross Margin | 47.31% |
|---|---|
| Operating Margin | 18.32% |
| Pretax Margin | 16.82% |
| Net Margin | 13.61% |
| EBITDA Margin | 24.53% |
| EBIT Margin | 18.85% |
| FCF Margin | 7.21% |
| Gross Margin (5Y Average) | 45.07% |
| Operating Margin (5Y Average) | 16.00% |
| Net Margin (5Y Average) | 10.97% |
Growth
Revenue grew 10.92% a year over 3 years, and EPS 16.99% a year.
| Revenue Growth (3Y CAGR) | +10.92% |
|---|---|
| Revenue Growth (5Y CAGR) | +10.72% |
| EPS Growth (3Y CAGR) | +16.99% |
| EPS Growth (5Y CAGR) | +13.57% |
| FCF Growth (3Y CAGR) | +53.39% |
| FCF Growth (5Y CAGR) | +7.66% |
| Operating Income Growth (3Y CAGR) | +18.67% |
Dividends and Yields
EHC pays out 5.88% of earnings as dividends.
| Dividend Per Share (Annual) | $0.84 |
|---|---|
| Dividend Yield | 0.61% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | -6.63% |
| Dividend Growth (5Y CAGR) | -8.97% |
| Payout Ratio | 5.88% |
| FCF Payout Ratio | 57.17% |
| Earnings Yield | 4.44% |
| FCF Yield | 3.37% |
| Buyback Yield | 2.05% |
| Shareholder Yield | 3.98% |
Peer Position
Against 12 similar companies, EHC has the 5th highest P/E and the 3rd highest P/S.
P/E RatioPeer median 17.6x
P/S RatioPeer median 1.2x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.19%
Dividend YieldPeer median 0.07%
| P/E Ratio | 22.5x vs 17.6x median |
|---|---|
| P/S Ratio | 2.1x vs 1.2x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +9.36% vs +7.19% median |
| Dividend Yield | 0.61% vs 0.07% median |
Analyst Forecast
Consensus estimates put revenue growth at 8.74% and EPS growth at 12.31% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +8.74% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +12.31% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About EHC
What is EHC's market cap?
Encompass Health has a market cap of $13.94B. Its enterprise value, which adds debt and subtracts cash, is $16.47B.
What is EHC's P/E ratio?
Encompass Health has a trailing P/E ratio of 22.5x and a forward P/E of 21.9x.
How many shares of EHC are outstanding?
Encompass Health has 98.30M shares outstanding. The count is down 2.19% from a year earlier.
Does EHC pay a dividend?
Yes. Encompass Health pays $0.84 a share a year, a dividend yield of 0.61%.
How much debt does EHC have?
Encompass Health has $2.60B of total debt and $76.20M of cash and equivalents, a net debt position of $2.52B.
EHC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts